Related Experiment Video
Updated: Apr 15, 2026

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
Published on: December 20, 2024
Megaloblastic anemia presenting with massive reversible splenomegaly
Vineet Behera1, Makarand Randive1, Praveen Sharma1
1Department of Internal Medicine, Armed Forces Medical College, Pune, 411040 India.
Megaloblastic anemia (MA) can cause massive splenomegaly, a rare but treatable condition. Prompt diagnosis and treatment of MA led to significant spleen size reduction in this case.
Area of Science:
- Hematology
- Internal Medicine
Background:
- Megaloblastic anemia (MA) is a common hematologic disorder.
- Splenomegaly is a frequent manifestation, typically mild to moderate.
- Massive splenomegaly is rarely associated with MA.
Observation:
- A patient presented with symptomatic anemia and massive splenomegaly.
- Extensive evaluation excluded other common causes of massive splenomegaly.
- The patient was diagnosed with megaloblastic anemia.
Findings:
- Megaloblastic anemia was confirmed as the cause of massive splenomegaly.
- Therapeutic trial for MA resulted in significant regression of spleen size.
- This case highlights an unusual presentation of MA.
Implications:
- Massive splenomegaly should be considered in the differential diagnosis of megaloblastic anemia.
- Early diagnosis and treatment of MA can effectively manage associated massive splenomegaly.
- Further research may elucidate the mechanisms linking MA and massive splenomegaly.
More Related Videos
04:40Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
Published on: November 4, 2022
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: